• GBC reiterated a Buy rating on Syzygy, keeping its EUR 2.7 target price with a valuation horizon of Dec. 31, 2027.
• H1 2026 revenue fell 14.2% to EUR 25.23 million; EBIT slipped to EUR 430,000, supported by cost cuts.
• Full-year guidance was maintained for revenue of EUR 50 million, implying a 3%-4% EBIT margin or EUR 1.5 million to EUR 2 million.
• GBC kept forecasts for revenue of EUR 50.02 million, EBIT of EUR 1.5 million; it sees EBIT rising to EUR 2.64 million in 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syzygy AG published the original content used to generate this news brief via EQS News (Ref. ID: rc_26412) on August 06, 2026, and is solely responsible for the information contained therein.